Imported malaria remains a diagnostic challenge in the United States
Malaria is not endemic in the United States, but it is not absent. Roughly 2,000 imported cases are diagnosed nationally each year, and 10% to 20% occur in children. A new multicenter retrospective study highlighted by Children’s Hospital of Philadelphia shows how easy those cases can be to miss. Researchers found that more than one in four pediatric patients treated for malaria in the US experienced a delay in their initial diagnosis.
That gap matters because malaria is a time-sensitive disease. Delays increase the risk that an infection will worsen before treatment begins, particularly in children, whose symptoms and disease course do not always mirror those of adults.
Travel patterns shape the risk profile
The study analyzed 171 pediatric malaria patients treated at nine US hospitals between 2016 and 2023. Most had a clear travel link: 73% had traveled to West Africa to visit friends and relatives. That detail is clinically important because it highlights where prevention and diagnostic attention need to be concentrated. Children visiting family abroad may not fit the stereotypes clinicians associate with business or adventure travel, yet they may be returning from high-risk malaria settings.
As one of the study authors noted, children are not little adults. Their travel motives differ, and their care pathways often do as well. That means prevention counseling, pre-travel prophylaxis, and post-travel screening need to account for the social reality of family-linked international travel rather than assuming a narrower traveler profile.
